Оценка эффективности использования Инотир® в сочетании с Белара® при синдроме поликистозных яичников

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/1863

Full metadata record

DC Field	Value	Language
dc.contributor.author	Бекмирзаева Ф.М., Шукуров Ф.И.	-
dc.date.accessioned	2025-06-22T09:35:17Z	-
dc.date.available	2025-06-22T09:35:17Z	-
dc.date.issued	2019	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/1863	-
dc.description.abstract	60 patients with polycystic ovary syndrome were examined. The main group consisted of 40 women who received combination therapy with the multicomponent drug Inotir®, in combination with chlormadinone acetate, ethinyl estradiol containing (COC) Belara®. The control group included 20 healthy women of reproductive age. The use of combination therapy led to the normalization of the menstrual cycle, had an impact on the structure and volume of the ovaries, antiandrogenic action and normalization of carbohydrate metabolism.	en_US
dc.language.iso	other	en_US
dc.publisher	Tashkent, Uzbekistan	en_US
dc.subject	polycystic ovary syndrome; treatment; Inotir®, Belard®, violation of carbohydrate metabolism	en_US
dc.title	Оценка эффективности использования Инотир® в сочетании с Белара® при синдроме поликистозных яичников	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
14.pdf	Оценка эффективности использования Инотир® в сочетании с Белара® при синдроме поликистозных яичников	402.87 kB	Adobe PDF	View/Open

DSpace JSPUI